v3.25.4
Share-based payments
12 Months Ended
Dec. 31, 2025
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Share-based payments Share-based payments
Accounting for share-based payments
Employee incentives include awards in the form of shares and share options, as well as offering employees the opportunity
to purchase shares on favourable terms. The cost of the employee services received in respect of the shares or share options
granted is recognised in the income statement over the period that employees provide services. The overall cost of the
award is calculated using the number of shares and options expected to vest and the fair value of the shares or options at
the date of grant.
The number of shares and options expected to vest takes into account the likelihood that applicable performance and
service conditions included in the terms of the awards will be met. For other share-based payment schemes such as
Sharesave and Sharepurchase, there are non-vesting conditions which must be met. Failure to meet the non-vesting
condition is treated as a cancellation, resulting in an acceleration of recognition of the cost of the employee services.
The fair value of shares is the market price ruling on the grant date, in some cases adjusted to reflect restrictions on
transferability. The fair value of options granted is determined using the Black-Scholes model to estimate the numbers of
shares likely to vest. The model takes into account the exercise price of the option, the current share price, the risk-free
interest rate, the expected volatility of the share price over the life of the option and other relevant factors. Market conditions
that must be met in order for the award to vest are also reflected in the fair value of the award, as are any other non-vesting
conditions – such as continuing to make payments into a share-based savings scheme.
The charge for the year arising from share-based payment schemes was as follows:
Charge for the year
2025
2024
2023
£m
£m
£m
Share Value Plan and Deferred Share Value Plan
315
287
254
Others
177
133
144
Total equity settled
492
420
398
Cash settled
13
9
3
Total Share-based payments
505
429
401
The terms of the main current plans are as follows:
Share Value Plan (SVP)
SVP awards have been granted to participants in the form of a conditional right to receive Barclays PLC shares or provisional
allocations of Barclays PLC shares which vest or are considered for release over a period of three, four, five or seven years.
Participants do not pay to receive an award or to receive a release of shares. SVP awards are also made to eligible employees
for recruitment purposes. All awards are subject to potential forfeiture in certain leaver scenarios.
Deferred Share Value Plan (DSVP)
The terms of the DSVP are materially the same as the terms of the SVP as described above, save that Executive Directors are
not eligible to participate in the DSVP and the DSVP operates over market purchase shares only.
Other schemes
In addition to the SVP and DSVP, the Barclays PLC Group operates a number of other schemes settled in Barclays PLC Shares
including Sharesave (both UK and Ireland), Sharepurchase (both UK and Overseas), and Barclays PLC Group Long Term
Incentive Plan. A delivery of upfront shares to ‘Material Risk Takers’ can be made as a Share Incentive Award (Holding
Period) under the SVP. A free share award was delivered under the SVP to all eligible employees in 2025, with this award
being subject to a two-year holding period.
Share option and award plans
The weighted average fair value per award granted, weighted average share price at the date of exercise/release of shares
during the year, weighted average contractual remaining life, and number of options and awards outstanding (including
those exercisable) at the balance sheet date were as follows:
2025
2024
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
£
£
in years
(000s)
£
£
in years
(000s)
SVP and DSVP1,2
2.87
3.09
1
381,279
1.52
1.74
1
441,713
Others1,3
1.49-3.57
3.03-4.01
0-2
35,395
0.81-2.1
1.72-2.13
0-2
43,901
SVP and DSVP are nil cost awards on which the performance conditions are substantially completed at the date of grant.
Consequently, the fair value of these awards is based on the market value at that date.
Sharesave has a contractual life of 3 years and 5 years, the expected volatility is 29.04% for 3 years and 26.48% for 5 years.
The risk free interest rates used for valuations are 3.47% and 3.56% for 3 years and 5 years respectively. The pure dividend
yield rates used for valuations are 1.99% and 2.14% for 3 years and 5 years respectively. The repo rates used for valuations
are (0.60)% and (0.69)% for 3 years and 5 years respectively. The inputs into the model such as risk free interest rate,
expected volatility, pure dividend yield rates and repo rates are derived from market data.
Movements in options and awards
The movement in the number of options and awards for the major schemes and the weighted average exercise price of
options was:
SVP and DSVP1,2
Others1,3
Number (000s)
Number (000s)
Weighted average
exercise price (£)
2025
2024
2025
2024
2025
2024
Outstanding at beginning of year/acquisition date
441,713
435,820
43,901
51,363
1.17
1.05
Transfers within the year4
(1,095)
(2,528)
391
1,780
Granted in the year
129,006
202,420
53,384
84,383
3.01
1.79
Exercised/released in the year
(169,166)
(171,810)
(60,633)
(90,721)
0.99
0.95
Less: forfeited in the year
(19,179)
(22,189)
(1,461)
(2,611)
1.36
1.20
Less: expired in the year
—
—
(187)
(293)
1.18
1.25
Outstanding at end of year
381,279
441,713
35,395
43,901
1.52
1.17
Of which exercisable:
—
—
8,013
4,956
0.94
1.23
Notes:
1  Options/award granted over Barclays PLC shares.
2  Weighted average exercise price is not applicable for SVP and DSVP awards as these are not share option schemes.
3 The number of awards within Others at the end of the year principally relates to Sharesave (number of awards exercisable at end of year was
4,323,541 (2024: 828,340)). The weighted average exercise price relates to Sharesave.
4  Awards of employees transferred between the Barclays Bank Group and the rest of the Barclays PLC Group.
Awards and options granted to employees and former employees of the Barclays Bank Group under the Barclays PLC Group
share plans may be satisfied using new issue shares, treasury shares and market purchase shares of Barclays PLC. Awards
granted to employees and former employees of the Barclays Bank Group under DSVP may only be satisfied using market
purchase shares of Barclays PLC.
There were no significant modifications to the share-based payments arrangements in 2025 and 2024.
As at 31 December 2025, the total liability arising from cash-settled employee share-based payments transactions was
£15m (2024: £10m).